4-O-methylation using a specific daunorubicin-blocked, nonproducing mutant provided the new anthracycline antibiotics 4-O-methylbetaclamycin T, 4-Omethylyellamycin A and 4-0-methyl-1 3-hydroxyoxaunomycin, from which 4-0-methyloxaunomycin and 4-O-methyl-6-deoxyoxaunomycin were then prepared by further photochemical 7V-demethylation. Antitumor activities in vitro and in vivo against L1210 cells were compared with those of their 4-O-demethyl derivatives. It was found that all the 4-0-methyl derivatives had a markedly reduced cytotoxicity in vitro as comparedwith the 4-0-demethyl compounds.However,some of them were endowedwith a significantly improved antitumor activity in vivo.
Microbial
4-O-methylation using a specific daunorubicin-blocked, nonproducing mutant provided the new anthracycline antibiotics 4-O-methylbetaclamycin T, 4-Omethylyellamycin A and 4-0-methyl-1 3-hydroxyoxaunomycin, from which 4-0-methyloxaunomycin and 4-O-methyl-6-deoxyoxaunomycin were then prepared by further photochemical 7V-demethylation. Antitumor activities in vitro and in vivo against L1210 cells were compared with those of their 4-O-demethyl derivatives. It was found that all the 4-0-methyl derivatives had a markedly reduced cytotoxicity in vitro as comparedwith the 4-0-demethyl compounds.However,some of them were endowedwith a significantly improved antitumor activity in vivo. 1837 In the continuing search for new antitumor anthracycline antibiotics from biosynthetically blocked mutants and by means of microbial conversion using antibiotic-nonproducing mutants, we have recently obtained the unique anthracycline antibiotics, oxaunomycin (7-0-daunosaminyl-^rhodQmycinone)1*, 1-hydroxyoxaunomycin (7-O-daunosaminyl-/?-isorhodomycinone)2) and 6-deoxyoxaunomycin (7-0- daunosaminyl-a-citromycinone)2). These compoundshad good antitumor activity against some murine tumors (unpublished data). However, they were too cytotoxic to be useful in therapy. Wehave observed in some instances that 4-O-methylation reduces the cytotoxic activity of anthracycline antibiotics without a decrease in any antitumor effect. Therefore, we attempted to obtain 4-O-methyl derivatives of the above compounds hoping to improve their antitumor effects by reducing their cytotoxicity.
In this paper, we describe the production of new 4-O-methyl derivatives3) of the rhodomycin-group of antibiotics (oxaunomycin, betaclamycin T4) and yellamycin A5)) by selective 4-O-methylation using a specific daunorubicin-blocked, nonproducing mutant and by a subsequent photochemical 7V-demethylation. We thus obtained new 4-O-methyl anthracyclines as summarized in Table 1 . Their antitumor activities in vitro and in vivo were also tested and evaluated in terms of the 4-O-methyl group.
Results

Microbial 4-O-Methylation
Test Microbial strain DKN-1 used for selective 4-O-methylation was a pigment-less nonproducing but f Present address: Faculty of Applied Biological Science, Hiroshima University, 1-4-4 Kagamiyama, Higashihiroshima 724, Japan * Corresponding author biotransformable isolate of D788-56) (4-O-methyl-1 0-methoxycarbonyl-1 3-deoxocarminomycin)-accumulating mutant strain 58NR-58, which had been derived from daunorubicin-producing Streptomyces sp. D788, strain KL-587). Strain 58NR-58 was damaged at the deesterification step of a methoxycarbonyl group of a presumptive precursor metabolite D788-68) (10-methoxycarbonyl-13-deoxocarminomycin) , so that daunorubicin production was stopped before a metabolite D788-l9) (10-carboxy-13-deoxocarminomycin) . Preliminary bioconversion test with strain DKN-1 was undertaken on some aimed monoglycosidic anthracyclines: D788-6 (7-0-daunosaminyl-£-rhodomycinone (RMN)), oxaunomycin, betaclamycin T (7-0-rhodosaminyl-/?-RMN) and yellamycin A (7-0-rhodosaminyl-a-citromycinone (CTN)). Tests were performed by adding the substrate anthracyclines to the growing culture, after which the bioconversion products were extracted with an organic solvent and analyzed by TLCand HPLC. In all cases, the bioconversion products were homogeneous when assayed by TLC. Our first concern was whether the bioconversion with strain DKN-1was limited to 4-0-methylation. The selective 4-0-methylation was thus confirmed by the bioconversion of D788-6 to D788-5 as shown in Table 2 . It was found that Rf values of the 4-O-methylated and unmethylated compounds were almost identical (0.28 for D788-5 and 0.27 for D788-6) although their retention times (Rts) in HPLC were greatly different (6.9minutes for D788-5 and 9.6minutes for D788-6; Rt ratio: 0.7 (6.9/9.6) Isolation and Identification of MC-1, MC-4and MC-7 To determine the structures of MC-1, MC-4and MC-7a large scale microbial conversion of betaclamycin T (425mg), yellamycin A (102mg) or oxaunomycin (425mg) was carried out with the growing culture of the mutant strain DKN-1. The fermentation broth was filtered and the anthracycline products were extracted from the mycelial cake with 0.7 volume of acetone. The acetone extract was concentrated in vacuo to about 0.25 volume. To the concentrate, 2 volumes of H2Owere added, adjusted to pH 2.0 with phosphoric acid and charged onto a column of Diaion HP-20 (42mm i.d. x 300mm, Mitsubishi Chemical Ind.) packed in acidic water (pH 2.0). After washing with 2 liters of dil phosphoric acid (pH 2.0) and 1 liter of40% aq MeOH(pH 2.0), the products were eluted with 80% aq MeOH(pH 2.0). Main fractions containing the objective compound were collected, diluted with 0.3 volume of water and adjusted to pH 8.0 with 4n NaOH. The anthracycline pigments were then extracted with CHC13and the extract was evaporated in vacuo to dryness. Yields of crude MC-1, MC-4and MC-7 were 265mg, 72mg and 121 mg, respectively.
The crude MC-1was purified by column chromatography on reverse phase silica gel (150ml, YMC gel 60A) which was developed stepwise with acetonitrile-water (15 : 85~20 : 80, pH 2.0, H3PO4). The fractions containing MC-1were adjusted to pH 8.0 with 1 n NaOH, and the pigment was extracted with CHC13and reextracted with 1%AcOH.After washing with toluene the aqueous solution was adjusted to pH 8.0 with 1 n NaOHand extracted with CHC13. After washing with H2Oand drying over Na2SO4, the CHCI3layer was concentrated in vacuo to a small volume, and an excess of «-hexane was added to precipitate 173mg of pure MC-1 as an orange powder.
The crude MC-4 was purified by preparative HPLC(column: CAPCELLPACC18 SG120, 5 /mi, 30mmi.d. x250mm, Shiseido, mobile phase: acetonitrile-water (25:75, adjusted to pH 2.0 with H3PO4), flow rate: 5 ml/minute, detection: UV at 254nm). From the fractions containing MC-4, 42mg of pure MC-4was obtained as a yellow powder after acidic extraction and hexane precipitation as described above.
The crude MC-7 was purified by preparative TLC (Silica gel 60 PF254, E. Merck) which was developed with CHC13-MeOH-H2O-AcOH-coned NH4OH(110:50: 5: 1 : 1). The MC-7 bands were scraped from the TLC plates and MC-7 was extracted with CHCl3-MeOH(5: 1). To the extract, the same volume of H2Owas added, and the aqueous layer was separated and washed with CHC13and toluene. The pigment was extracted with CHC13after the pH was raised to 8.0. The organic layer was concentrated in vacuo to a small volumeand an excess of «-hexane was added to precipitate ll mgof pure MC-7as an orange powder. The structural determination of MC-1, MC-4 and MC-7 was carried out by MS, XH and 13C NMR analyses and TLCanalysis of the sugar components obtained by acid hydrolysis.
The physico-chemical properties of MC-1, MC-4 and MC-7 are shown in Table 3 . The UVand visible light absorption spectra of MC-1and MC-7were comparatively similar to those of their parent compounds, while those of MC-4were obviously different. MC-4exhibited a maximumabsorption at 413 nm which shifted by 12nm in comparison with that (425nm) of yellamycin A5). This conspicuous shift seemed to be a result of 4-O-methylation as seen with ll-deoxydoxorubicin and its related compounds10), and their 4-O-demethyl derivatives1 1}. The IR absorptions related to the quinone carbonyl groups of MC-1, MC-4and MC-7were different from those of their parent compounds. Two maximum absorptions at 1580cm"1 and 1610cm"1 related to hydrogen bonded quinone carbonyl groups were observed with MC-1and MC-7although only one maximumabsorption at 1600cm" 1 with betaclamycin T and oxaunomycin. One additional maximumabsorption at 1660cm"1 observed in MC-4indicated a presence of a nonhydrogen bonded quinone carbonyl group. These results also suggested a modification of the hydroxyl group at C-4. On total acid hydrolysis, MC-1, MC-4 and MC-7 were hydrolyzed as previously described12) and gave an orange aglycone, a yellow aglycone and an orange aglycone, respectively. The Rf values of the aglycones on TLC using CHCl3-MeOH(20: 1) were 0.33, 0.19 and 0.ll, respectively, and were different from those (0.35, 0.26 and 0.35, respectively) of their parental aglycones, jS-rhodomycinone, a-citromycinone and /?-rhodomycinone. The Rts of the aglycones obtained by HPLCanalysis (system C) were 5.61, 4.75 and 3.76minutes, respectively, and were also different from those (8. In *H NMRspectra of MC-1and MC-4, the chemical shifts were almost identical to those of their parent compounds, betaclamycin T and yellamycin A, respectively, except for one additional singlet (<5 4.1) which indicated a presence of a methoxyl group. The long range connectivity between the proton at <5 4.1 and C-4 in MC-1 and MC-4 revealed that the methoxyl group is linked to the C-4 position as shown in Fig. 1 . Similarly HMBCanalysis of MC-7 revealed that the hydroxyl group at C-4 of oxaunomycin was methylated, while the signals for the side chain at C-9 of MC-7was entirely different from those of oxaunomycin. Correlated signals were observed between 3 4.01 (quartet, 13-H) and 3 1.38 (doublet, 14-CH3) and the molecular ion appeared at 30 mass units upper than the corresponding ion of oxaunomycin, indicating that C-13 of MC-7was oxidized to possess a hydroxyl group substituent. From all these findings, the structures of MC-1, MC-4 and MC-7were determined to 4-Omethylbetaclamycin T, 4-O-methylyellamycin A and 4-0-methyl-l 3-hydroxyoxaunomycin, respectively. The 13C NMRspectra of each also supported these structures. Table 6 . Inhibitory activities of MC-NMC-7and their 4-0-demethyl compounds on growth and nucleic acid synthesis of cultured L1210 leukemia cells. In the inhibition test for nucleic acid synthesis, cultured L1210 leukemia cells (8 x 105 cells/ml) were exposed for 60 minutes to the drugs supplemented with 14C-labeled uridine or thymidine (0.05 juCi/ml), and the incorporation of the radioisotopes into acid insoluble material was measured. For the growth inhibition test, cultured L1210 leukemia cells (5 x 104cells/ml) were exposed for 48 hours to the drugs and the viable cells were counted by coulter counter. IC50 is expressed as a drug concentration required to inhibit by a 50% of control growth, and DNAand RNAsyntheses of cultured L1210 cells.
Abbreviations: BCM-T, betaclamycin T; OXM, oxaunomycin; YLM-A, yellamycin A.
Af-didemethyl-MC-1, 7V-monodemethyl-MC-4 and TV-didemethyl-MC-4, respectively. Mass and NMR data described in experimental part confirmed their structures.
Antitumor Activity in vitro and in vivo The antitumor activities in vitro of MC-1~MC-7against cultured L1210 cells were examined and the results are shown in Table 6 in comparison with those of their 4-0-demethyl derivatives. The cytotoxicities of MC-1~MC-6 were obviously reduced. Especially, the 4-0-methyl derivatives, MC-4~MC-6, obtained from yellamycin A illustrate this remarkably reduced cytotoxicity. Their IC50 values are more than l.O jUg/ml while that of yellamycin A is 0.007 /ig/ml. The cytotoxicities of TV-didemethyl compounds, MC-3 and MC-6, were almost the same as those of MC-1and MC-4, respectively, while those of Nmonodemethyl compounds, MC-2 and MC-5, were reduced as seen with N-monodemethyl derivatives of some rhodosamine-containing anthracyclines14). The cytotoxicity of MC-7 (13-hydroxy-MC-3) was 6.9 times weaker than that of MC-3. MC-3inhibited DNAsynthesis more strongly than RNAsynthesis as seen with oxaunomycin1}.
Antitumor effects in vivo of MC-1~MC-3 were tested in mice bearing leukemia L1210 by daily ip administration from day 1 to 10. MC-1~MC-3 had a maximumantitumor activity of 231%, 176% and 183% (T/C) at an optimum dose of 5.0, 1.25 and 0.63 mg/kg/day, respectively. Under the same conditions betaclamycin T, LB-1 and oxaunomycin had a T/C value of 182%, 170% and 204% at an optimum dose of 0.63, 0.06 and 0.20 mg/kg/day, respectively.
Discussion
By microbial 4-0-methylation using a specific daunorubicin-blocked, nonproducing mutant and by conversion mediumand 0.5 ml of a methanolic solution of a substrate (5 mg/ml) was added to each flask.
HPLC Analysis
Conversion rate and purity of the products, and the aglycones generated by acid hydrolysis were analyzed by HPLC using a Shimadzu HPLC system consisting of LC-6A pump, SPD-6AV detector and Chromatopak C-R3A integrator with a reverse-phase column, YMC-A312(ODS) (Yamamura Chemical Laboratories Co., LTD.). Acetonitrile-0.05m ammonium formate (pH 4.0) (system A: 38 : 62, system B: 30:70) and acetonitrile-water (45: 55; adjusted to pH 2.0 with H3PO4) (system C) were used as the mobile phase and run at a flow rate of 1.0ml/minute. Samples were dissolved in the mobile phase and 10fA samples were injected. UVabsorbance was monitored at 254nmand visible light absorbance at 436nm or 495n
Biological Activity In vitro cytotoxicity and inhibition of DNAand RNAsyntheses in cells of murine L1210 leukemia were assayed according to the method previously described16).
4-0-Methyl-/?-rhodomycinone MC-1 (20mg) was dissolved in 20ml of0.1 n HC1 and heated at 85°C for 30minutes in a water bath. The aglycone was extracted with CHC13and then purified by preparative TLC on silica gel plates (PF254, E. Merck) using a developing solvent of CHCl3-MeOH(20: 1). One major band was scraped from the plates and extracted with CHCl3-MeOH(10 : 1). The eluate was washed with H2O, dried over Na2SO4, concentrated to a small volume and precipitated with an excess of «-hexane to give an orange powder Each of them was further purified by the repeated preparative TLC. Each compound extracted was evaporated, dissolved in 1% AcOHand washed with toluene. After raising the pH to 8.0, the pigment was extracted with CHCI3. The extract was washed with satd NaCl solution, dried over Na2SO4, and concentrated to a small volume. To the concentrate, an excess of «-hexane was added to precipitate an orange powder. This procedure gave 21.2mg of MC-2 and 27.1 mg of MC-3, respectively.
MC - 
